Month: June 2021

Most of us have heard the phrase “success is about who you know,” and that couldn’t be more true. The people we surround ourselves with are a direct reflection of our life and success. But one thing that facilitates this is emotional intelligence, or EQ for short. It’s not just about how smart you are,
0 Comments
The observational extended study of the previously reported 12-month randomized TAILOR-PCI trial shows genotype-guided antiplatelet therapy after percutaneous coronary intervention (PCI) did not significantly reduce ischemic events compared with conventional therapy, after a median of 39 months. This was the same finding as in the original trial.  However, there is more to this than meets
0 Comments
With more than 30 million people infected and 550,000 dead, the U.S. is among the nations hardest hit by the COVID-19 pandemic. From job loss to housing insecurity to mental distress, the social, psychological and economic hardships brought on by the pandemic are extensive and likely to outlast the pandemic itself. To better understand the
0 Comments
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. June 4, 2021 — The Pfizer COVID-19 vaccine produces lower levels of antibodies against the Delta variant, known as B.1.617.2 and discovered in India, according to a new study published Thursday in The Lancet. The antibody levels also appear to be
0 Comments
Once a virus infects a cell, neighboring cells are likely to become infected by interactions that are dependent on the cell and the virus in question. For example, cell-to-cell spread is facilitated in HIV by viral synapses, which also allow for escape from neutralizing antibodies. Low-level drug inhibitors are able to suppress infection if applied
0 Comments
vadadustat Treatment for Anemia Associated with Chronic Renal Failure Akebia and Otsuka Announce FDA Acceptance for Filing of New Drug Application for Vadadustat for the Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis and Not on Dialysis CAMBRIDGE, Mass. and TOKYO, June 1, 2021 /PRNewswire/ – Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with
0 Comments
PRINCETON, N.J.–(BUSINESS WIRE) May 27, 2021 — Bristol Myers Squibb (NYSE:BMY) today announced that the U.S. Food and Drug Administration (FDA) approved Zeposia (ozanimod) 0.92 mg for the treatment of adults with moderately to severely active ulcerative colitis (UC), a chronic inflammatory bowel disease (IBD).1 Zeposia, an oral medication taken once daily, is the first
0 Comments
We’re all individuals, with unique interests, passions, likes, and dislikes. And yet, when it comes to Father’s Day gifts, a lot of the offerings fall back on tired stereotypes. Now, we’re not saying that tools aren’t handy, or that scented shaving products aren’t a treat – but for dads who like something a little different,
0 Comments
Treatment with filgotinib among patients with ankylosing spondylitis was associated with declines in inflammation in the spine, a post-hoc analysis of a multicenter randomized trial found. “Ankylosing spondylitis is a chronic inflammatory disease affecting the sacroiliac joints and spine and can result in structural damage and disability,” noted Xenofon Baraliakos, MD, of Ruhr University in
0 Comments
June is National Cancer Survivors Month! To honor survivors, we will be sharing stories from folks with cancer and their caregivers. Today we hear from Erin. 37-Year-Old Cancer Survivor and Mom of Four Shares Her Survival Story to Help Others An advanced Stage III colon cancer diagnosis was the last thing I expected to receive
0 Comments
A novel, ultra-long-acting oral formulation of the antipsychotic risperidone (Risperdal) only needs to be taken once weekly and appears to be safe and effective, results of a new phase 2 study suggest. The new formulation, LYN-005 (Lyndra Therapeutics), quickly reached therapeutic levels in patients, provided sustained exposure to risperidone active moiety over 7 days, and
0 Comments
In the heat of the moment, it can be easy to let our emotions get the better of us. But by tuning-in to yourself, you can take back control and channel your anger in productive and healthy ways As the emotion often underlying societal issues such as violence, crime, internet trolling, and even terrorism, anger
0 Comments
A significant proportion of patients want telehealth services to remain a permanent part of healthcare, newly released results from a national poll show. Sponsored by the American Psychiatric Association (APA), the findings show 82% of survey respondents have used telehealth services and 43% want to them to continue, even after the pandemic is over. The
0 Comments
Our partnership with ScottishPower began in 2012, since then it’s raised over £30m. We’re thrilled to announce that we’re extending this extraordinary partnership for another three years. This means that the incredible employees, suppliers and customers of ScottishPower will continue to help us fund our life-saving research until 31 March 2024. Alongside their creative fundraising
0 Comments
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Jun. 1, 2021– Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that it has initiated the rolling submission process with the U.S. Food and Drug Administration for a Biologics License Application (BLA) for the licensure of its mRNA COVID-19 Vaccine to prevent COVID-19 in individuals 18 years of age
0 Comments
pacritinib Treatment for Myelofibrosis CTI BioPharma Announces Acceptance of NDA Granted with Priority Review of Pacritinib for Treatment of Patients with Myelofibrosis SEATTLE, June 1, 2021 /PRNewswire/ – CTI BioPharma Corp. (Nasdaq: CTIC) today announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for pacritinib as a treatment for myelofibrosis patients with severe thrombocytopenia
0 Comments
FDA Approves Brexafemme (ibrexafungerp) as the First and Only Oral Non-Azole Treatment for Vaginal Yeast Infections JERSEY CITY, N.J., June 02, 2021 (GLOBE NEWSWIRE) — Scynexis, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to overcome and prevent difficult-to-treat and drug-resistant fungal infections, today announced that the U.S. Food and Drug Administration (FDA) has
0 Comments
Healthcare providers have been at the forefront of many changes to our healthcare systems and society during the pandemic, as they treat COVID-19 patients and face a constant threat of exposure. Personal protective equipment (PPE) has become the norm, and it has undoubtedly kept healthcare workers safer. Now, as the pandemic may be nearing its
0 Comments
Practical ways to calm your breath to ease stress and anxiety right now Stress is a normal part of our lives. The way we’re built as humans means that certain events and situations can trigger our stress response system, creating internal panic and alarming our body of danger. But, although stress is a natural, human
0 Comments